Literature DB >> 23206599

Neuron-intrinsic inhibitors of axon regeneration: PTEN and SOCS3.

Xueting Luo1, Kevin K Park.   

Abstract

Our understanding of how axon regeneration is controlled in both the peripheral and central nervous systems remains fragmentary. Research into the regenerative capacity of adult neurons has elucidated PTEN and SOCS3 as distinctive but complementary arms of the regenerative program. These molecules act as negative regulators of major signaling pathways and impact the processes occurring in the cell body, such as protein translation and transcription, and in the axons, such as cytoskeleton assembly. In this review, we summarize the role of PTEN and SOCS3 in limiting axon regeneration and discuss the molecular and cellular mechanisms underlying their growth-inhibitory effects.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23206599     DOI: 10.1016/B978-0-12-398309-1.00008-1

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  12 in total

Review 1.  Optic nerve regeneration in mammals: Regenerated or spared axons?

Authors:  Dietmar Fischer; Alan R Harvey; Vincent Pernet; Vance P Lemmon; Kevin K Park
Journal:  Exp Neurol       Date:  2017-07-14       Impact factor: 5.330

2.  The effect of systemic PTEN antagonist peptides on axon growth and functional recovery after spinal cord injury.

Authors:  Yosuke Ohtake; Dongsun Park; P M Abdul-Muneer; Hui Li; Bin Xu; Kartavya Sharma; George M Smith; Michael E Selzer; Shuxin Li
Journal:  Biomaterials       Date:  2014-03-12       Impact factor: 12.479

Review 3.  Harnessing the power of cell transplantation to target respiratory dysfunction following spinal cord injury.

Authors:  Brittany A Charsar; Mark W Urban; Angelo C Lepore
Journal:  Exp Neurol       Date:  2016-08-13       Impact factor: 5.330

4.  Overlapping transcriptional programs promote survival and axonal regeneration of injured retinal ganglion cells.

Authors:  Anne Jacobi; Nicholas M Tran; Wenjun Yan; Inbal Benhar; Feng Tian; Rebecca Schaffer; Zhigang He; Joshua R Sanes
Journal:  Neuron       Date:  2022-06-28       Impact factor: 18.688

5.  Mitochondrial STAT3 is negatively regulated by SOCS3 and upregulated after spinal cord injury.

Authors:  Keun Woo Park; Ching-Yi Lin; Etty N Benveniste; Yu-Shang Lee
Journal:  Exp Neurol       Date:  2016-08-05       Impact factor: 5.330

6.  AAV2-BDNF promotes respiratory axon plasticity and recovery of diaphragm function following spinal cord injury.

Authors:  Brittany A Charsar; Michael A Brinton; Katherine Locke; Anna Y Chen; Biswarup Ghosh; Mark W Urban; Sreeya Komaravolu; Karthik Krishnamurthy; Rupert Smit; Piera Pasinelli; Megan C Wright; George M Smith; Angelo C Lepore
Journal:  FASEB J       Date:  2019-10-02       Impact factor: 5.834

7.  Respiratory axon regeneration in the chronically injured spinal cord.

Authors:  Lan Cheng; Armin Sami; Biswarup Ghosh; Hannah J Goudsward; George M Smith; Megan C Wright; Shuxin Li; Angelo C Lepore
Journal:  Neurobiol Dis       Date:  2021-05-08       Impact factor: 7.046

8.  Identifying molecular features associated with psychoneurological symptoms in women with breast cancer using multivariate mixed models.

Authors:  Qing Zhou; Colleen Jackson-Cook; Debra Lyon; Robert Perera; Kellie J Archer
Journal:  Cancer Inform       Date:  2015-05-07

9.  A recessive form of extreme macrocephaly and mild intellectual disability complements the spectrum of PTEN hamartoma tumour syndrome.

Authors:  Tobias Schwerd; Andrea V Khaled; Manfred Schürmann; Hannah Chen; Norman Händel; André Reis; Gabriele Gillessen-Kaesbach; Holm H Uhlig; Rami Abou Jamra
Journal:  Eur J Hum Genet       Date:  2015-10-07       Impact factor: 4.246

Review 10.  Subcellular targeting and dynamic regulation of PTEN: implications for neuronal cells and neurological disorders.

Authors:  Patricia Kreis; George Leondaritis; Ivo Lieberam; Britta J Eickholt
Journal:  Front Mol Neurosci       Date:  2014-04-01       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.